Boston Scientific signs deal with BG Medicine to use heart diagnostic test

03/31/2011 | MassDevice.com (Boston)

BG Medicine has entered an agreement with Boston Scientific allowing the latter to use its galectin-3 test for heart failure to pinpoint patients who might be candidates for a cardiac resynchronization treatment. The deal will allow Boston Scientific to use BG's biomarker discovery technologies to identify other biomarkers that could help predict patients' responses to the therapy.

View Full Article in:

MassDevice.com (Boston)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Actuary
Meridian Health Plan
Detroit, MI